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SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comFor procedural characteristics, stent diameter, total stent length, and number of
stents used were similar between the two groups (6.60.5 mm vs. 6.80.4 mm,
p¼0.09, 179131 mm vs. 167112 mm, p¼0.73, and 2.01.2 vs. 1.70.9,
p¼0.32, respectively) . For post-procedural IVUS ﬁndings, there were no signiﬁcant
differences in minimum stent cross-sectional area (CSA), maximum stent CSA,
radial stent symmetry index, and axial stent symmetry index (13.53.9 mm2 vs.
14.64.5 mm2, p¼0.39, 22.95.7 mm2 vs. 24.16.1 mm2, p¼0.50, 0.840.04
vs. 0.780.14, p¼0.11, and 0.600.12 vs. 0.630.19, p¼0.59, respectively).
Distal lumen CSA was signiﬁcantly smaller in the ISR group (13.64.7 mm2 vs.
20.17.3 mm2, p< 0.05).
Conclusions: DES implantation in small vessels was associated with ISR.
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Background: Treatment for symptomatic peripheral arterial disease (PAD)
includes peripheral endovascular interventions (PVI) and lower extremity bypass
surgery (LEB). Limited comparative effectiveness data exists between the two
therapies.
Methods: 1858 patients from two large integrated healthcare systems undergoing
PVI (n¼883) and LEB (n¼975) for claudication or critical limb ischemia (CLI) from
January 2005-December 31st, 2011 were examined. We examined the association
between procedure type (PVI vs LEB) and 30-day post-procedure complications,
subsequent target lesion revascularization (TLR) and major amputations.
Results: Patient undergoing PVI had lower rates of post-procedure complications
than patients treated with LEB (11.9% vs. 37.1%, p< 0.01) In contrast, rates of
TLR were greater for PVI compared to LEB in patients presenting with claudication
(3 year TLR was 19.0% [95% CI 15.5, 22.5] and 8.3% [95% CI 5.2, 11.4]
respectively, log-rank p< 0.001) and for patients presenting with CLI (3 year TLR
was 31.6% [95%CI 25.2, 37.9] and 16.0% (95% CI 12.8, 19.2) respectively, log-
rank p-< 0.01) (Figure 1). There were no differences in the rates of major ampu-
tations between the two groups in the CLI cohort (21.2% vs. 25.4%, p>0.05).
Patterns were consistent when adjusted by inverse propensity score weights or
within propensity-matched cohorts.Conclusions: Conclusion: In patients with symptomatic PAD, revascularization by
PVI was associated with less procedural complications but required reintervention
more often than LEB. Limb salvage was similar whether endovascular or open stra-
tegies were pursued.B160 JACC Vol 64/11/Suppl B j September 13–17, 20TCT-546
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Background: Subintimal tracking and subsequent failure to re-enter the true lumen is
a frequent cause of procedural failure in treating chronic total occlusions (CTO) of
infrainguinal arteries.
Methods: 452 CTO lesions were treated between July 2005 and May 2014 from the
multicenter Excellence in Peripheral Artery Disease (XLPAD) registry
(NCT01904851). Angiography and intravascular ultrasound were used to conﬁrm
subintimal or true lumen crossing.
Results: True lumen crossing occurred in 72.6% and subintimal tracking in 27.4%.
Baseline features, ankle-brachial index and Rutherford category were similar in both
groups. Subintimal tracking was more frequent in longer lesions (154.972.9 mm vs.
131.376.4 mm; p¼0.004), CTO with blunt distal stumps (92% vs. 83%; p¼0.003),
and presence of side branches at the distal stump (93% vs. 86%; p¼0.059; Figure 1).
Subintimal procedures were more frequently stented (92% vs. 62%), with a higher
stent to lesion ratio (2.4  1.1 vs. 1.2  1.2), p< 0.001 for both. True lumen re-entry
failed in 8%, and occurred more frequently in below-the-knee and heavily calciﬁed
lesions.Conclusions: Subintimal tracking during infrainguinal arterial CTO crossing is more
prevalent in long lesions, with blunt distal stumps and side branches, leading to
extended procedure and ﬂuoroscopy durations.Cerebral Intervention (and Acute Stroke Therapies)
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Background: To evaluate the safety and efﬁciency of vertebral angioplasty and
stenting (VAS) in symptomatic patients.
Methods: 120 angioplasties in 114 pts (M:82) mean age 67,9  6,8 years (22-84) left
69. All pts had multivascular diseases: carotid (CA):71, subclavian (SA): 33, coro-
nary: 75. Atheromatous lesions: 116, inﬂammatory: 4. Mean lesion length: 9,5 +/- 2,9
mm. Mean % stenosis 83.6  7.8, mean arterial diameter : 4,8  0,6 mm (4-6). 112
lesions at VO segment (ostium), 6 at V1 and 2 at V2 segments. Indications for14 j TCT Abstracts/Cerebral Intervention (and Acute Stroke Therapies)
www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMangioplasty: dizziness (110), bilateral weakness (12), visual changes 14), diplopia
(12), drop attacks (24), TIA (15), ataxia (6). A protection device (ﬁlter) used in 12 pts.
25 SA angioplasties performed at the same time of VAS, 10 CA. All angioplasties
performed by femoral approach, 4 by brachial approaches after failure of femoral
approach. (2 successes).
Results: Technical success 118/120 (99%). 6 lesions treated by angioplasty alone: 3
VO (ﬁrst 3 pts. 2 V1, 1 V2 lesion). 1 pt (inﬂammatory disease) treated by cutting
balloon alone. 111 lesions treated with stents (direct stenting: 96). Peripheral balloon
expandable stents (n¼23), self expandable stents (n¼4 for 3 V1 and one V2 lesions).
88 coronary stents (20 DES). 1 pt developed a TIA during the procedure. No
neurological complications at 30 days Clinical success 112/114 (99%) Post-procedure
arterial diameter: 4,60  0,8 mm (4-6). Mean residual stenosis 2,5  3,9 %. In 12 pts
treated with protection devices, visible debris removed in 9 (6 Filterwire, 2 Fibernet) 1
Angioguard with the same amount of debris as during Carotid Stenting) 9 pts (8%)
developed a symptomatic restenosis during the follow-up (mean: 33.4.29.9 months),
3 after PTA alone, 5 after PTA and stent (1 occlusion treated medically, 7 stenoses
successfully treated with PTA). No restenosis after DES implantation at 1 year.
Conclusions: VAS can be performed safely and effectively with a high technical
success rate, a low complication rate, a low restenosis rate and a durable clinical
success in patients with symptomatic VA stenosis. Stents seem to improve immediate
and long-term results. The role of protection devices and D.E.S has to be discussed.Carotid Intervention
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Background: Proximal occlusion (PO) and distal ﬁlter (DF) serve for cerebral
embolic protection during carotid artery stenting (CAS). The incidence of new cere-
bral lesions at diffusion-weighted magnetic resonance imaging (DW-MRI) represents
a surrogate endpoint for embolization, though the clinical impact is controversial. We
perform a meta-analysis of DW-MRI studies comparing PO and DF during CAS.
Methods: Scientiﬁc databases and websites were searched. The primary endpoint was
the incidence of new cerebral lesions at DW-MRI; secondary endpoints were the
incidence of new ipsilateral and new contralateral cerebral lesions at DW-MRI and
death/cerebrovascular events (CVE).
Results: A total of 292 patients from 6 studies received CAS with PO (n¼ 143) or DF
(n¼ 149). At DW-MRI after 48 hours 129 patients (49%) presented new cerebral
lesions. PO versus DF did not reduce the risk of new cerebral lesions (OR [95%
conﬁdence interval] 0.74 [0.26-2.07], P¼ 0.57), neither ipsilateral (0.72 [0.24-2.16],
P¼ 0.55), nor contralateral (0.55 [0.26-1.20], P¼ 0.13). At 90-day follow-up, PO
versus DF did not reduce the risk of death/CVE (0.58 [0.18-1.90], P¼ 0.37). High-
grade baseline stenoses and the presence of symptoms signiﬁcantly modiﬁed the risk
estimates for new cerebral lesions. However, there was no relationship between new
cerebral lesions and the risk of death/CVE.
Conclusions: In this meta-analysis, one half of patients receiving protected CAS
developed new embolic cerebral lesions at DW-MRI, although the overwhelming
majority was asymptomatic. Cerebral protection with PO versus DF did neither reduce
cerebral embolization nor impact clinical outcomes. The grade of baseline stenosis and
the presence of symptoms impact the risk of cerebral embolization associated with
protected CAS.
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Background: Carotid stenting (CS) is considered to be non-inferior to carotid end-
arterectomy (CEA) for treatment of symptomatic carotid disease with similar stoke
and death rates. It is still to be determined if staged CS followed by CABG could beJACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/Caalso non-inferior to combined CEA and CABG for the concomitant presence of
coronary and carotid artery disease. Therefore we aimed to evaluate the non-inferiority
of staged CS compared to combined CEA and CABG by using all the prospective
available studies.
Methods: Pub Med, Chocrane and Scopus were systematically searched up to April
2014. Subjects of analysis were 30 days post surgery incidence of stroke and death for
carotid and coronary revascularization using either CS or CEA with CABG. We used
Fixed or Random Effect analysis using the Cochrane Handbook of Systematic
Reviews.
Results: Out of 350 articles, three prospective studies were identiﬁed and disclosed a
total of 94 patients on the CS and 140 in the CEA group respectively. There was a
trend towards lower stroke in the CAS group compared to the CEA (4.2% vs 9.2%,
p¼0.1; Figure 1.A) and no difference on mortality rate (5.3% vs. 7.8%, p¼0.42;
Figure 1.B).
Conclusions: Our analysis suggests that staged CS and CABG might not be inferior to
combined CEA and CABG. Also the overall mean incidence of 30 days stroke is
below the average reported on most observational studies. Therefore clinical ran-
domized studies are warranted.TCT-550
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Background: Circulating biomarkers of atherosclerosis, in isolation, are largely
ineffective in risk stratiﬁcation of carotid plaque (CS) symptomatic transformation
while plaque morphology is increasingly implicated. Intravascular ultrasound (IVUS,
20MHz transducer) provides axial resolution 0.12mm. However, conventional
-phenotypic- virtual histology (VH-IVUS) plaque evaluation has poor between-cen-
ter/-observer reproducibility. To provide basis for prospective comprehensive evalu-
ation, we sought to determine whether quantitative measures of key rupture-risk
plaque components are related to selected circulating biomarkers.
Methods:We developed an algorithm for fully-quantitative VH-IVUS analysis of key
plaque components known for their role in plaque rupture/thrombosis. Inter-transducer
and inter-observer reproducibility of qVH-IVUS analysis including minimal ﬁbrous
cap (FC) thickness, and peak conﬂuent NC area, thickness and arc. Next we employed
the qVH-IVUS algorithm to evaluate CS lesions in 200 consecutive patients (age 47–
83, 63.4% men, h/o CS-attributable symptoms in 50.3%) presenting for potential CS
revascularization and determined the levels of a panel of biomarkers.
Results: qVH-IVUS revealed signiﬁcant differences in minimal FC thickness
(0.410.04 v 0.340.05 v 0.160.02 v 0.190.03mm), peak conﬂ NC area (3.00.2
v 2.50.3 v 4.40.4 v 3.40.5mm2), arc (87.16 v 67.26 v 121.69 v
94.09deg) and thickness (0.880.04 v 1.070.07 v 1.340.06 v 1.160.11mm);
asympt CS in absence of contralat symptoms, asympt CS+contralat symptoms,
recently symptomatic and remotely symptomatic CS, p< 0.001 all. hsCRP was not
correlated with min FC (p¼0.74) or NC area (p¼0.48). TIMP correlated with min FC
(r¼0.34, p¼0.001). Modest though highly signiﬁcant correlations were identiﬁed
between Lp-PLA2 and conﬂ NC area (r¼0.3, p¼0.0001), HDL and conﬂ NC thckn
(r¼-0.21, p¼0.002). Selected ﬁbrin clot properties showed an association with VH-
determined plaque content. Fibrinogen level correlated with % plaque ﬁbrotic content
(r¼0.19, p¼0.008).
Conclusions: These ﬁndings provide novel insights into circulating biomarker/
quantitative plaque morphology associations that may be relevant to risk
stratiﬁcation.rotid Intervention B161
